Data center design/build firm Bick Group has announced the acquisition of Blue Mountain Labs (BML), a consulting firm focused on the adoption of cloud computing within enterprise and government organizations. Terms ... Read More
Bayer MaterialScience announced last week that he has opened the world’s larger pilot facility for manufacture of carbon nanotubes at CHEMPARK Leverkusen in Germany. “Current forecasts predict an annual growth rate ... Read More
Specialty drug and medical device maker Baxter International Inc. said Monday it will spend up to $330 million to acquire ApaTech, a privately held British concern that makes bone and soft ... Read More
Baxter International Inc. and Nycomed said Tuesday the Food and Drug Administration approved the surgical sealant TachoSil, which is used to control blood loss. TachoSil is manufactured and patented by Nycomed, ... Read More
BASF, the world’s largest chemicals maker, has sealed a deal to buy Cognis, a German maker of additives, for at least 3.3 billion euros ($4.1 billion), The Wall Street Journal reported, ... Read More
German chemical company BASF SE said Thursday that the economic recovery and a push by customers to restock their own inventories helped it nearly triple its first-quarter net profit. The company, ... Read More
Barnes-Jewish Hospital and its physician partners at Washington University School of Medicine are one of 14 hospitals and medical institutions nationwide included on U.S. News & World Report’s list of “America’s ... Read More
Metal and plastic packaging supplier Ball Corp. said Tuesday that it has agreed to sell its U.S.-based plastic packaging business to Australian packaging company Amcor Ltd. for $280 million. The deal ... Read More
Just days after losing a large contract to supply armored vehicles for the British army, BAE Systems PLC on Friday announced two weapons deals that in the long term could be ... Read More
AstraZeneca waded into the competitive rheumatoid arthritis market on Tuesday by buying rights to Rigel Pharmaceuticals‘ next-generation drug R788 for up to $1.245 billion, Reuters reported. The deal is a big ... Read More